State Street Health Care Select Sector SPDR ETF
$168.64−1.25 (−0.74%)
- Expense ratio
- 0.08%
- Fund size
- $42.8B
- 1Y return
- +26.4%
- Yield · Last 12 months
- 1.50%
- Holdings
- 61
- Volume · 30D
- 9.7M sh
- NAV per share
- $168.96
- 52W range
The ETF.net XLV Grade
Score 84 of 100 sits in the A band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 98Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.AScore 84Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.AScore 74Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.AScore 100Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.DScore 39Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 87Category rank
Our read on XLV
ALive since 1998, XLV is the original way to own health care: about 60 S&P 500 names, a 0.08% fee, and one of the busiest tickers in the sector. Big pharma and device makers, not small-cap biotech.
The fund seeks to track, before expenses, the price and yield performance of the Health Care Select Sector Index, which represents the health care sector of the S&P 500 Index.
Why people hold it
- 0.08% a year against a cohort median of 0.50%. That ties it with FHLC as the cheapest in the group and edges VHT at 0.09%.
- One of the most actively traded funds in its category, which generally keeps bid-ask spreads thin whether you trade 10 shares or 10,000.
- Launched December 1998 as one of the first US sector funds, and it has tracked its S&P 500 health care index closely ever since.
- Covers the whole sector in one line: pharma, devices, providers, biotech, life-science tools and health tech. Pays quarterly.ssga.com
Worth knowing
- Cap-weighted and about 60 names deep, so the largest drug and device makers carry most of the weight.ssga.com
- S&P 500 members only. Mid- and small-cap health care names sit outside the mandate.
- One sector, one set of headlines: drug pricing rules, patent expirations and policy shifts move the whole basket together.
XLV Holdings
- Stocks
- 61
- 61%
- LLY
Sectors
- Health Care99.3%
- Technology0.7%
Geography
- United States97.70%
- Ireland2.30%
XLV Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
XLV$12,641
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | XLV |
|---|---|
| Year to date | +11.1% |
| 1 month | −2.3% |
| 3 months | +13.6% |
| 1 year | +26.4% |
| 3 years | +11.1% |
| 5 years | +7.0% |
| 10 years | +10.6% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | XLV |
|---|---|---|
| 2026 YTD | +11.1% | |
| 2025 | +14.5% | |
| 2024 | +2.5% | |
| 2023 | +2.1% | |
| 2022 | −2.1% | |
| 2021 | +26.0% | |
| 2020 | +13.3% |
XLV in the news
XLV Dividends
- 1.50%
- $2.55
- $0.64 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 21, 2026 | Pays Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |
XLV Risk
- 14.3%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.45
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −17.1%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.51
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
XLV Cost
0.08%
XLV0.08%
- The middle half of Health Care (Broad) funds
- Median 0.50%
No Health Care (Broad) fund charges less.